Literature DB >> 24362787

Recurrent episodes of hemorrhagic alveolitis in relapsing catastrophic antiphospholipid syndrome: the same side of the dark moon.

Filippo Pieralli1, Maddalena Grazzini, Vieri Vannucchi, Antonio Mancini, Daniele Cammelli, Carlo Nozzoli.   

Abstract

Catastrophic antiphospholipid syndrome (CAPS) is a rare variant of antiphospholipid syndrome characterized by widespread thrombotic microangiopathy and multiorgan failure. Clinically, CAPS signs and symptoms can mimic vasculitis of systemic lupus erythematosus, disseminated intravascular coagulation, and thrombotic thrombocytopenic purpura. CAPS is burdened by high mortality, nearly 50% in most series. However, patients surviving the acute phase rarely suffer of CAPS relapses. Moreover, concomitant pulmonary hemorrhagic alveolitis is a very rare complication warranting an ominous prognosis. Only few reports of relapsing CAPS are described in literature, and pathogenetic mechanisms are poorly understood and the optimal treatment is yet unknown. We report a case of a young man suffering from multiple relapses of CAPS and recurrent hemorrhagic pulmonary alveolitis refractory to aggressive combination treatment.

Entities:  

Mesh:

Year:  2013        PMID: 24362787     DOI: 10.1007/s10067-013-2454-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

1.  Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?

Authors:  K C Cerveny; A D Sawitzke
Journal:  Lupus       Date:  1999       Impact factor: 2.911

2.  Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years.

Authors:  C M Neuwelt; D I Daikh; J A Linfoot; D A Pfister; R G Young; R L Webb; S S London; R A Asherson
Journal:  Arthritis Rheum       Date:  1997-08

Review 3.  Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome.

Authors:  Ronald A Asherson
Journal:  Immunobiology       Date:  2005-10-20       Impact factor: 3.144

4.  Relapsing catastrophic antiphospholipid syndrome: report of three cases.

Authors:  Ronald A Asherson; Gerard Espinosa; Solomon Menahem; Janet Yinh; Silvia Bucciarelli; Xavier Bosch; Ricard Cervera
Journal:  Semin Arthritis Rheum       Date:  2007-10-30       Impact factor: 5.532

5.  Preventing death in the catastrophic antiphospholipid (Asherson) syndrome.

Authors:  Mario García-Carrasco; Ricardo O Escárcega; Claudia Mendoza-Pinto; Alfonso Zamora-Ustaran; Ivet Etchegaray-Morales; Jorge Rojas-Rodriguez; Luis E Escobar-Linares; Ricard Cervera
Journal:  Isr Med Assoc J       Date:  2007-08       Impact factor: 0.892

6.  [Three episodes of acute multiorgan failure in a woman with secondary antiphospholipid syndrome].

Authors:  A Undas; J Swadźba; R Undas; J Musiał
Journal:  Pol Arch Med Wewn       Date:  1998-12

7.  CAPS Registry.

Authors:  R Cervera
Journal:  Lupus       Date:  2012-06       Impact factor: 2.911

8.  Relapsing catastrophic antiphospholipid syndrome potential role of microangiopathic hemolytic anemia in disease relapses.

Authors:  Gerard Espinosa; Ignasi Rodríguez-Pintó; José A Gomez-Puerta; Guillermo Pons-Estel; Ricard Cervera
Journal:  Semin Arthritis Rheum       Date:  2012-07-10       Impact factor: 5.532

9.  Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.

Authors:  R Cervera; J Font; J A Gómez-Puerta; G Espinosa; M Cucho; S Bucciarelli; M Ramos-Casals; M Ingelmo; J-C Piette; Y Shoenfeld; R A Asherson
Journal:  Ann Rheum Dis       Date:  2005-02-11       Impact factor: 19.103

Review 10.  Rheumatic manifestations of cocaine use.

Authors:  Jonathan Graf
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

View more
  2 in total

1.  Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome.

Authors:  Anne Angelillo-Scherrer; Behrouz Mansouri Taleghani; Frauke Förger; Gabriela M Baerlocher; Thomas Pabst; Alexander Pöllinger; Yara Banz; Thomas Geiser; Johanna A Kremer Hovinga; Alicia Rovó
Journal:  Blood Adv       Date:  2019-09-10

Review 2.  Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.

Authors:  Sarah Abramson Stoots; Lindsay Lief; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2019-09-06       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.